COVID-19 相关趋势:整形与重建外科的 Medicare 使用情况
该研究利用 CMS Medicare 数据库分析 2013 至 2023 年整形与重建外科医生的计费服务,共纳入 4,903,961 项服务、2,970,140 名受益人及 3,767 名外科医生。结果显示服务量、Medicare 标准化支付、非 Medicare 支付、报销比例及申报费用均下降,中断时间序列分析显示 2020 年服务量显著下降且 2020 年后支付与费用斜率发生显著变化。
要点
- 2013 至 2023 年 Medicare 整形与重建外科服务量下降 31.9%。
- 同期平均 Medicare 标准化支付下降 39.9%,平均申报费用下降 12.8%。
- 2020 年服务量出现显著下降(p < 0.001),此后支付与费用斜率显著改变。
核心结论
- COVID-19 大流行加剧了整形与重建外科 Medicare 使用量和报销的下降趋势,使服务 Medicare 患者的外科医生面临更大挑战。
研究设计与样本
- 基于 CMS Medicare Physician & Other Practitioners 数据库的回顾性分析,纳入 2013 至 2023 年整形与重建外科医生计费的所有操作代码。
- 共分析 4,903,961 项服务、2,970,140 名受益人及 3,767 名外科医生,并按器官系统进行亚组分析。
- 采用中断时间序列分析(ITSA),断点设为 2020 年,所有金额经通胀调整至 2023 年。
主要发现
- 2013 至 2023 年间,服务量下降 31.9%,平均 Medicare 标准化支付下降 39.9%,平均非 Medicare 支付下降 33.7%。
- 同期报销比例下降 10.9%,平均申报费用下降 12.8%。
- ITSA 显示 2020 年服务量显著下降(p < 0.001),2020 年后 Medicare 支付(p = 0.009)和平均费用(p = 0.001)的斜率发生显著变化。
临床怎么用
- 整形与重建外科医生应认识 Medicare 使用量和报销的下降趋势,以预防 Medicare 患者接受整形与重建外科治疗的障碍增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The Medicare population is a subset of plastic surgery patients with unique needs and characteristics. Studies before COVID-19 have shown decreasing reimbursements and increasing charges. We aimed to characterize changes in Medicare reimbursements and charges in plastic and reconstructive (PR) surgery since the pandemic. METHODS: The CMS Medicare Physician & Other Practitioners database was used to analyze all procedural codes billed by PR surgeons from 2013 to 2023. Subgroup analysis was conducted based on the organ system (integumentary, musculoskeletal, nervous, and other). Primary outcomes were the total number of services billed, average Medicare standardized payment, average submitted charge, and average percent reimbursed per visit. An interrupted time series analysis (ITSA) was conducted with the break point set in 2020. All dollar amounts were inflation-adjusted to 2023. RESULTS: A total of 4,903,961 services for 2,970,140 beneficiaries were billed to Medicare by 3767 surgeons. Between 2013 and 2023, there were decreases in volume (-31.9%), average Medicare standardized payment (-39.9%), average non-Medicare payment (-33.7%), percent reimbursed (-10.9%), and charge (-12.8%). ITSA revealed a significant drop in volume in 2020 (p < 0.001) and significant changes in slope after 2020 in Medicare payments (p = 0.009) and average charge (p = 0.001). CONCLUSIONS: Exacerbated by the COVID pandemic, the downward trends in Medicare utilization and reimbursements for PR surgery have made it more challenging for surgeons serving Medicare recipients. Acknowledging these trends is vital to prevent increased care barriers to PR surgery and ensure better health for Medicare patients.
引用
- Zhang J, Bajaj A, Sriram N, et al. COVID-19-associated trends in Medicare utilization for plastic and reconstructive surgery. J Plast Reconstr Aesthet Surg. 2026. PMID: 41762759. doi:10.1016/j.bjps.2026.02.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。